Paolo Calabrò - Concepedia

Author

Paolo Calabrò

University of Campania "Luigi Vanvitelli"ORCID

Also Known As

Alberto Berenguer Jofresa, Alessandro Broccoli, Alessandro Sciahbasi, Arturo Cesaro, Calabrò, Paolo, Carlo Antonio Bossi, Claudio Ferri, D. Masarone, Emilia Antonucci, F. Mascia

630

Publications

18.4K

Citations

H-Index

133

Concepts

All Affiliations

University of Campania "Luigi Vanvitelli"University of Naples Federico II Ospedale Monaldi Sapienza University of Rome Ospedale Sant'Anna

About

Paolo Calabrò is an author at University of Campania "Luigi Vanvitelli" specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	75	4.8K
2	Public Health	20	31	2.8K
3	Health Sciences	7	7	448
4	Engineering	5	5	95
5	Natural Sciences	1	1	22

Paolo Calabrò

156

Publications

11.4K

Citations

H-Index

Page 1

	Year	Citations
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial Marco Valgimigli, Andrea Gagnor, Paolo Calabrò, The Lancet Percutaneous Coronary InterventionCardiovascular DiseaseCoronary Artery DiseasePatient SafetyVascular Surgery	2015	1.3K
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era Salvatore De Rosa, Carmen Spaccarotella, Cristina Basso, European Heart Journal	2020	937
Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells Paolo Calabrò, James T. Willerson, Edward T.H. Yeh Circulation	2003	577
Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes Marco Valgimigli, Enrico Frigoli, Sergio Leonardi, New England Journal of Medicine	2015	378
Resistin Promotes Smooth Muscle Cell Proliferation Through Activation of Extracellular Signal–Regulated Kinase 1/2 and Phosphatidylinositol 3-Kinase Pathways Paolo Calabrò, Ismael Samudio, James T. Willerson, Circulation	2004	328
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial Marco Valgimigli, Enrico Frigoli, Sergio Leonardi, The Lancet ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseCoronary Artery DiseaseFinal 1-Year Results	2018	289
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons, The Lancet Family MedicineMetabolic SyndromeLipid DisorderCardiovascular DiseaseHealth Policy	2021	285
Atrial Myocardial Deformation Properties Predict Maintenance of Sinus Rhythm After External Cardioversion of Recent-Onset Lone Atrial Fibrillation Giovanni Di Salvo, Pio Caso, Rosalia Lo Piccolo, Circulation	2005	262
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry Pasquale Paolisso, Luca Bergamaschi, Gaetano Santulli, Cardiovascular Diabetology	2022	204
Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives Francesco Natale, M Tedesco, R. Mocerino, European Journal of Echocardiography	2009	195

Page 1